Amarin Corp Plc (AMRN)

[Whalatane]

Thx for the Barrons article
From a quick look ....AT-527 shows the viral load decreasing in both the placebo and active arm ..over time . Its decreasing in the active ( drug ) arm faster but IMHO not dramatically . So its faster recovery time in those that are recovering anyway ...from the data I quickly looked at .
What we're interested in is decreased need for hospitalization in those most likely to need hospitalization ...ie older with co morbidities like heart disease .

The inclusion data for one on the Molnupiravir trials require males to abstain from sex ( or wear protection ) for 90 days which indicates there may be a signal for birth defects some where in the data . Its an unusual inclusion criteria .
Again ...from a quick look .

As Raf is continually reminding us .....most young people who get Covid do not need hospitalization and recover . Some may develop long Covid , and the young unvaccinated may pass Covid on to those older and of higher risk... but thats another discussion .
Those that are currently overwhelming the hospitals in Idaho and parts of other states are mostly unvaccinated , older with co morbidity's . Thats where the acute need is ...reducing the rate of hospitalization and death .

If Vascepa helps in that ...reducing hospitalization and death in the most high risk group ( older etc ) ..its an existing approved drug that is already in pharmacies that can easily be dispensed .
MITIGATE will tell us if V works or not for this group

Kiwi